Related Experiment Video
Updated: Aug 11, 2026
06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Vaccines for pandemic influenza
Catherine J Luke1, Kanta Subbarao
1National Institutes of Health, Bethesda, Maryland 20892, USA.
Emerging Infectious Diseases
|February 24, 2006
Summary
Developing and testing avian influenza vaccines is crucial for pandemic preparedness. These studies will help prevent disease spread and reduce severity if a pandemic virus emerges in humans.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Recent highly pathogenic avian influenza outbreaks in Asia have caused human infections, increasing pandemic concerns.
- Vaccination is recognized as the most effective strategy to prevent pandemic influenza spread and mitigate disease severity.
Purpose of the Study:
- To produce and test live attenuated and inactivated vaccine seed viruses against pandemic avian influenza strains.
- To establish manufacturing principles and gain experience critical for rapid vaccine deployment during a pandemic.
- To enhance understanding of avian influenza virus biology and mammalian host interactions.
Main Methods:
- Production of live attenuated and inactivated vaccine seed viruses.
- Preclinical studies and clinical trials for vaccine evaluation.
- Investigating avian influenza virus behavior in mammalian models.
Main Results:
- Vaccine seed virus production and testing protocols were established.
- Preclinical and clinical data demonstrated vaccine potential.
- Insights into avian influenza virus pathogenesis in mammals were gained.
Conclusions:
- Developing and testing avian influenza vaccines is essential for pandemic preparedness.
- Manufacturing experience and established principles are vital for rapid response.
- Further research will improve understanding and control of avian influenza.
Related Concept Videos
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:51Vaccinations
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...